Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Madrigal Pharmaceuticals Inc (MDGL)

$93.49 1.97 (2.15%)

16:07 EST MDGL Stock Quote Delayed 15 Minutes

Volume:

Previous Close $93.49

Market Cap 1.33B

PE Ratio -37.55

EPS -2.49

Volume (Avg. Vol.) 83,500

Day's Range 91.76 - 94.74

52-Week Range 74.05 - 148.18

Dividend & Yield N/A (N/A)

MDGL Stock Predictions, Articles, and Madrigal Pharmaceuticals Inc News

From InvestorPlace
From the Web

5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH

By Aaron Levitt, InvestorPlace Contributor Sep 26, 2018

Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.

4 Biotech Stocks With Leaky Pipelines

By Regina Borsellino Apr 10, 2018

A strong pipeline can make or break biotech stocks, ensuring strong profits for years to come. These four biotech companies don't make the cut.

13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market

From Benzinga Feb 5, 2020

Non-alcoholic steatohepatitis, or NASH, is a metabolic disorder caused by a buildup of fat in the liver, leading to liver inflammation and damage. It belongs to a group of...

Benzinga's Top Upgrades, Downgrades For January 30, 2020

From Benzinga Jan 30, 2020

Upgrades For Hess Corp (NYSE: HES), ScotiaBank upgraded the stock from Sector Underperform to Sector Outperform. In the fourth quarter, Hess showed an EPS of ($0.60),...

Canaccord likes Madrigal Pharma in premarket analyst action

From Seeking Alpha Jan 30, 2020

Galmed Pharmaceuticals (NASDAQ:GLMD) resumed with Overweight rating and $14 (142% upside) price target at Cantor Fitzgerald.Madrigal Pharmaceuticals (NASDAQ:MDGL) initiated with Buy rating and $198 (1

The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut

From Benzinga Jan 29, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) 10X Genomics Inc (NASDAQ...

The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics

From Benzinga Jan 28, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ...

Stocks That Hit 52-Week Lows On Monday

From Benzinga Jan 27, 2020

Before 10 a.m. ET Monday, 234 stocks made new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Exxon Mobil (NYSE: XOM)....

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell